Literature DB >> 19535744

Clinical neuropathy in HIV/AIDS: an eight-year review of hospitalized patients in Sokoto, northwestern Nigeria.

S A Isezuo1, A Z Sani, E Ezunu, S Maiyaki, C H Njoku, A Obembe.   

Abstract

HIV/AIDS is a multi-systemic disease that targets mainly the immune and nervous systems. Although about 4.4% of Nigerians are infected with HIV, data on the spectrum of HIV-related nervous disease in this population is rare. This study describes the neurological manifestations of HIV/AIDS in northern Nigeria. We undertook retrospective and descriptive analyses of the demographic, clinical, neurologic and laboratory data of all hospitalized HIV/AIDS adults in a referral hospital in northwestern Nigeria. The study period covered 2000 to 2007. We studied 322 HIV/AIDS patients (218 men, 104 women) aged 33.4 +/- 11.4 years (range: 18-65 years) who constituted 3.5% of the total medical admissions. HIV transmission was exclusively by heterosexual intercourse involving multiple partners. The majority (70.2%) was married and 78.9% were in stage III/IV HIV/AIDS disease. Fifty-two (16.2%) had CD4+ T-cell count determination, the mean value being 220 +/- 147.2 cells/m(3), and 58 (18.0%) were on highly active antiretroviral therapy. Fifty-one (15.8%) had neurological complications dominated by central nervous diseases including encephalitis (17.6%), dementia (16.2%) and stroke (14.9%). Peripheral nerve involvements were relatively infrequent. Compared with HIV/AIDS patients without neurological complications, a significantly higher proportion of those with HIV-associated neuropathy had a stage IV disease (30% versus 9.4%, chi(2) = 19.5, P < 0.001). Neurological complications, particularly central nervous diseases, are an important cause of morbidity in the HIV/AIDS population.

Entities:  

Mesh:

Year:  2009        PMID: 19535744     DOI: 10.1258/td.2008.080313

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  4 in total

1.  Acute EEG findings in HIV-infected Zambian adults with new-onset seizure.

Authors:  Omar K Siddiqi; Melissa A Elafros; Izukanji Sikazwe; Gretchen L Birbeck; Lisa Kalungwana; Michael J Potchen; Christopher M Bositis; Igor J Koralnik; William H Theodore
Journal:  Neurology       Date:  2015-03-04       Impact factor: 9.910

2.  Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.

Authors:  M A Cosenza-Nashat; A Bauman; M-L Zhao; S Morgello; H-S Suh; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

3.  The pattern and predictors of mortality of HIV/AIDS patients with neurologic manifestation in Ethiopia: a retrospective study.

Authors:  Tesfaye Berhe; Yilma Melkamu; Amanuel Amare
Journal:  AIDS Res Ther       Date:  2012-04-10       Impact factor: 2.250

4.  Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China.

Authors:  Rongrong Yang; Hong Zhang; Yong Xiong; Xien Gui; Yongxi Zhang; Liping Deng; Shicheng Gao; Mingqi Luo; Wei Hou; Deyin Guo
Journal:  AIDS Res Ther       Date:  2017-05-02       Impact factor: 2.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.